EW vs EYE · P/E 47, rev $1.39B vs rev $437.3M
Edwards Lifesciences Corp (EW) versus National Vision Holdings Inc (EYE) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
National Vision Holdings Inc (EYE) is a specialty retail company listed on US.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported EYE revenue for 2024-12-28 was $437.3M. Net income was -$28.6M. Revenue was down 3.2% from 2024-09-28 to 2024-12-28. EYE currently screens at market cap $1.93B.
EW currently screens at market cap $49.91B and trailing P/E 46.9. EYE currently screens at market cap $1.93B.
Not investment advice. Open the EW and EYE stock pages for the full models.
Not investment advice.